These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8636765)

  • 1. Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Solal-Céligny P; Brice P; Brousse N; Caspard H; Bastion Y; Haïoun C; Bosly A; Tilly H; Bordessoule D; Sebban C; Harousseau JL; Morel P; Dupas B; Plassart F; Vasile N; Fort N; Leporrier M
    J Clin Oncol; 1996 Feb; 14(2):514-9. PubMed ID: 8636765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.
    Decaudin D; Bosq J; Tertian G; Nedellec G; Bennaceur A; Venuat AM; Bayle C; Carde P; Bendahmane B; Hayat M; Munck JN
    J Clin Oncol; 1998 Feb; 16(2):579-83. PubMed ID: 9469344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).
    Morschhauser F; Mounier N; Sebban C; Brice P; Solal-Celigny P; Tilly H; Feugier P; Fermé C; Copin MC; Lamy T
    Cancer; 2010 Sep; 116(18):4299-308. PubMed ID: 20549824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
    Redman JR; Cabanillas F; Velasquez WS; McLaughlin P; Hagemeister FB; Swan F; Rodriguez MA; Plunkett WK; Keating MJ
    J Clin Oncol; 1992 May; 10(5):790-4. PubMed ID: 1373760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
    Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
    J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.
    Boogaerts MA; Van Hoof A; Catovsky D; Kovacs M; Montillo M; Zinzani PL; Binet JL; Feremans W; Marcus R; Bosch F; Verhoef G; Klein M
    J Clin Oncol; 2001 Nov; 19(22):4252-8. PubMed ID: 11709569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.
    Brice P; Bastion Y; Lepage E; Brousse N; Haïoun C; Moreau P; Straetmans N; Tilly H; Tabah I; Solal-Céligny P
    J Clin Oncol; 1997 Mar; 15(3):1110-7. PubMed ID: 9060552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
    J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
    Hagenbeek A; Eghbali H; Monfardini S; Vitolo U; Hoskin PJ; de Wolf-Peeters C; MacLennan K; Staab-Renner E; Kalmus J; Schott A; Teodorovic I; Negrouk A; van Glabbeke M; Marcus R
    J Clin Oncol; 2006 Apr; 24(10):1590-6. PubMed ID: 16575010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Solal-Celigny P; Lepage E; Brousse N; Reyes F; Haioun C; Leporrier M; Peuchmaur M; Bosly A; Parlier Y; Brice P
    N Engl J Med; 1993 Nov; 329(22):1608-14. PubMed ID: 8232429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Ribrag V; Tilly H; Casasnovas O; Bosly A; Bouabdallah R; Delarue R; Boue F; Bron D; Feugier P; Haioun C; Offner F; Coiffier B
    Eur J Cancer; 2013 Mar; 49(4):904-10. PubMed ID: 23273434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
    Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M
    Lancet Oncol; 2008 Apr; 9(4):352-8. PubMed ID: 18342572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
    Casasnovas RO; Haioun C; Dumontet C; Gabarre J; Richard B; Lederlin P; Caillot D; Stamatoullas A; Morel P; Quesnel B; Blay JY; Bouabdallah K; Gisselbrecht C
    Haematologica; 2000 May; 85(5):502-7. PubMed ID: 10800167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.
    Sorensen JM; Vena DA; Fallavollita A; Chun HG; Cheson BD
    J Clin Oncol; 1997 Feb; 15(2):458-65. PubMed ID: 9053466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte.
    Coiffier B; Neidhardt-Bérard EM; Tilly H; Belanger C; Bouabdallah R; Haioun C; Brice P; Péaud PY; Pico JL; Janvier M; Solal-Celigny P; Brousse N
    Ann Oncol; 1999 Oct; 10(10):1191-7. PubMed ID: 10586336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New initiatives with fludarabine monophosphate in hematologic malignancies.
    Keating MJ; O'Brien S; Robertson LE; Kantarjian H; Dimopoulos M; McLaughlin P; Cabanillas F; Gregoire V; Yang LY; Gandhi V
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):13-20. PubMed ID: 7694371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
    Tobinai K; Watanabe T; Ogura M; Morishima Y; Ogawa Y; Ishizawa K; Minami H; Utsunomiya A; Taniwaki M; Terauchi T; Nawano S; Matsusako M; Matsuno Y; Nakamura S; Mori S; Ohashi Y; Hayashi M; Seriu T; Hotta T
    J Clin Oncol; 2006 Jan; 24(1):174-80. PubMed ID: 16330664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
    J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of fludarabine phosphate for gastric adenocarcinoma. An Illinois Cancer Center trial.
    Kilton LJ; Ashenhurst JB; Wade JL; Schilsky RL; Shiomoto G; Blough RR; French SL; Benson AB
    Invest New Drugs; 1994; 12(2):163-6. PubMed ID: 7532162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
    Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R
    Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.